None listed
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Suman Meena
Eligibility
Inclusion criteria
Inclusion criteria: Postmenopausal women with c/o bleeding per vagina
Exclusion criteria
Exclusion criteria: Women with bleeding disorder/blood dyscrasia,Women on anticoagulant,Women with vaginal bleeding from vulval cause,Women with menopausal hormonal therapy Women with history of perineal trauma,Deranged liver function test, thrombocytopenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the clinical features in postmenopausal bleeding,To differentiate various histopathology finds in postmenopausal bleeding.Timepoint: 78 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To observe the USG finding in postmenopausal bleeding, To co-relate the various histopathological finding with the clinical featuresTimepoint: 78 weeks | — |
Countries
India
Contacts
Public ContactNupur Mittal
Uttar Pradesh University of Medical Sciences
Outcome results
None listed